Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Earnings
Pharma
Regeneron's Eylea franchise stumbles on several fronts in Q1
After consecutive setbacks at the FDA, Regeneron's string of recent troubles with its Eylea franchise is continuing to pull down the drugmaker.
Fraiser Kansteiner
Apr 29, 2025 2:50pm
Novartis builds momentum with new drug launches
Apr 29, 2025 10:52am
AbbVie plots $10B US outlay as pharma tariff threat looms
Apr 25, 2025 11:52am
BMS accentuates the positive after Cobenfy trial flop
Apr 24, 2025 11:31am
Roche works to mitigate US tariff impact with exemption plea
Apr 24, 2025 10:48am
J&J lifts 2025 sales guidance despite looming tariff threat
Apr 15, 2025 11:55am
